This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Related letters  • Similar articles in JAMA  Topic Collections  • Neurology  • Cerebrovascular Disease  • Stroke  • Patient-Physician Relationship/ Care  • Psychosocial Issues  • Psychiatry  • Depression  • Statistics and Research Methods  • Diagnosis  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 121 words of the full text and any section headings.

To the Editor: Dr Robinson and colleagues¹ reported that poststroke patients randomized to either escitalopram or problem-solving therapy had a lower annual incidence of depression compared with those prescribed placebo. Although the authors discussed the finding that both treatments outperformed placebo, they did not make a direct statistical comparison between the active treatments. It would be valuable to know how psychosocial treatment compared with prescription medication.

The reported incidence data showed that the rate of depression was approximately the same in both escitalopram (8.5%) and problem-solving therapy (11.9%) groups. This difference does not appear to be either clinically or statistically significant. The authors could enhance the value of their research by providing this additional piece of analysis.

Financial Disclosures: None reported.

Jeffrey Lacasse, PhD
jeffreylacasse@mac.com
College of Human Services
Arizona State University
Phoenix

Jonathan Leo, PhD
Department of Neuroanatomy
DeBusk College of Osteopathic Medicine
Lincoln Memorial University
Harrogate, Tennessee

1. Robinson RG, Jorge RE, Moser DJ; et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA. 2008;299(20):2391-2400. FREE FULL TEXT

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2008;300(15):1757-1758.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Escitalopram and Problem-Solving Therapy for Prevention of Poststroke Depression: A Randomized Controlled Trial
Robert G. Robinson, Ricardo E. Jorge, David J. Moser, Laura Acion, Ana Solodkin, Steven L. Small, Pasquale Fonzetti, Mark Hegel, and Stephan Arndt
JAMA. 2008;299(20):2391-2400.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Escitalopram, Problem-Solving Therapy, and Poststroke Depression
Olaf Schulte-Herbrüggen and Stefan Röpke
JAMA. 2008;300(15):1757.
EXTRACT | FULL TEXT  

Escitalopram, Problem-Solving Therapy, and Poststroke Depression
Michael Dettling, Carolin Opgen-Rhein, and Ion Anghelescu
JAMA. 2008;300(15):1757.
EXTRACT | FULL TEXT  

Escitalopram, Problem-Solving Therapy, and Poststroke Depression
Alice Rasmussen, Jamal A. Hanash, and Per Bech
JAMA. 2008;300(15):1758.
EXTRACT | FULL TEXT  

Escitalopram, Problem-Solving Therapy, and Poststroke Depression—Reply
Robert G. Robinson, Ricardo E. Jorge, and Stephan Arndt
JAMA. 2008;300(15):1758-1759.
EXTRACT | FULL TEXT